AIDS
Scope & Guideline
Elevating Science, Enhancing Practice
Introduction
Aims and Scopes
- Clinical Research on HIV Treatment:
The journal publishes studies investigating the efficacy and safety of antiretroviral therapies, including new drug regimens and their effects on viral load suppression, resistance, and patients' quality of life. - Epidemiology and Public Health:
Research focused on the epidemiological trends of HIV, including incidence, prevalence, and risk factors, as well as the effectiveness of HIV prevention strategies like pre-exposure prophylaxis (PrEP) and community-based interventions. - Comorbidities and Complications:
Studies addressing the intersection of HIV with other health conditions, such as cardiovascular diseases, mental health disorders, and metabolic syndromes, highlighting the need for integrated care models. - Social and Behavioral Aspects of HIV:
Research that explores the social determinants of health affecting HIV transmission and treatment, including stigma, discrimination, and the impact of socioeconomic factors on access to care. - Innovative Technologies and Interventions:
The journal encourages the exploration of new technologies in HIV care, such as digital health interventions, machine learning applications for predicting care outcomes, and novel diagnostic tools.
Trending and Emerging
- Impact of COVID-19 on HIV Care:
Recent studies are increasingly examining the effects of the COVID-19 pandemic on HIV testing, treatment adherence, and health outcomes, highlighting the need for integrated responses to concurrent health crises. - Mental Health and HIV:
There is a growing body of literature focusing on the mental health of individuals living with HIV, emphasizing the importance of addressing psychological comorbidities in comprehensive HIV care. - Comprehensive Care Models:
Research on integrated care models that address both HIV and non-HIV-related health issues is on the rise, reflecting the need for holistic approaches to patient management. - Long-Acting Antiretroviral Therapies:
The development and evaluation of long-acting injectable antiretroviral therapies are trending, as they promise to improve adherence and reduce the burden of daily medication regimens. - Social Justice and Equity in HIV Care:
Emerging studies are increasingly focusing on the social justice aspects of HIV care, including the effects of stigma, discrimination, and access to services among marginalized populations.
Declining or Waning
- Traditional Risk Factor Studies:
There has been a noticeable decrease in studies focusing solely on traditional risk factors for HIV transmission, such as injection drug use, as the field has shifted towards more complex models incorporating social determinants. - Longitudinal Studies Without Interventional Focus:
The frequency of purely observational studies lacking a clear intervention or treatment component has declined, with more emphasis being placed on studies that evaluate the effectiveness of specific interventions. - Basic Science Research on HIV Pathogenesis:
While foundational research remains critical, there has been a decreasing trend in basic science studies that do not directly translate into clinical applications or interventions for HIV treatment and prevention. - Regional Studies in High-Incidence Areas:
Research specifically focusing on high-incidence regions has waned, possibly due to the global emphasis on broader epidemiological trends and the need for generalizable findings.
Similar Journals
INTERNATIONAL JOURNAL OF STD & AIDS
Empowering research to combat global health challenges.INTERNATIONAL JOURNAL OF STD & AIDS is a prominent publication dedicated to advancing the understanding and treatment of sexually transmitted diseases and HIV/AIDS. Published by SAGE Publications Ltd, this esteemed journal has been contributing to the medical community since 1990, with a convergence of studies spanning to 2024. With its ISSN 0956-4624 and E-ISSN 1758-1052, the journal is recognized for its rigorous peer-reviewed research and has successfully positioned itself in the second quartile (Q2) of Dermatology and Public Health, alongside notable rankings in Infectious Diseases and Pharmacology. Currently based in the United Kingdom, this journal serves as a crucial resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and critical reviews that address global health challenges. Although it does not offer Open Access, the journal continues to maintain its reputation as a vital reference point for those invested in the fields of dermatology, public health, and infectious diseases.
Infectious Agents and Cancer
Transforming cancer research with groundbreaking studies on infectious agents.Infectious Agents and Cancer is a pivotal open access journal published by BMC, dedicated to advancing research at the intersection of infectious diseases and oncology. Since its inception in 2006, this journal has provided a platform for the exploration of the complex relationships between infectious agents and cancer development, aimed at researchers, healthcare professionals, and students alike. With a broad scope encompassing epidemiology and cancer research, the journal holds an impressive ranking in the Q3 quadrant for epidemiology, infectious diseases, and oncology in 2023, while also featuring in the Q4 category for cancer research. This distinguished journal not only contributes to the enrichment of scientific knowledge but also fosters collaborative efforts towards innovative solutions in the fight against cancer. Being part of the UK publishing landscape, the journal is accessible to a global audience, ensuring that vital research findings are disseminated widely to inform policy and practice in health sciences.
Journal of the International Association of Providers of AIDS Care
Advancing Knowledge in HIV/AIDS Care and ResearchJournal of the International Association of Providers of AIDS Care, published by SAGE PUBLICATIONS INC, is a distinguished open-access journal dedicated to the field of HIV/AIDS care and research. Since its inception in 2002, the journal has provided an essential platform for the dissemination of high-quality, peer-reviewed scholarly articles that advance knowledge in exciting areas such as dermatology, immunology, and infectious diseases. With an impact factor that highlights its role in shaping ongoing discourse, the journal boasts a strong reputation, reflected in its Q1 status in Dermatology and consistent ranking in the top tiers for immunology and infectious diseases in the Scopus Ranks. This commitment to excellence ensures that researchers, healthcare professionals, and students have access to the latest advancements and best practices in HIV/AIDS prevention and care. As a pivotal resource in the global health landscape, the journal stands at the forefront of efforts to combat the challenges presented by this ongoing epidemic.
Journal of Clinical Virology Plus
Transforming clinical virology through open-access research.The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.
CURRENT OPINION IN INFECTIOUS DISEASES
Fostering Critical Discussions in Infectious Disease TrendsCURRENT OPINION IN INFECTIOUS DISEASES, published by Lippincott Williams & Wilkins, is a premier journal that focuses on the latest developments and understanding in the field of infectious diseases. With its ISSN 0951-7375 and E-ISSN 1473-6527, this journal has gained recognition for its pivotal role in advancing knowledge from 1988 to its current publications in 2024. Boasting an impressive Q1 ranking in both Infectious Diseases and the Medical Microbiology category, it holds a reputable position among the top journals in the field. The journal serves as an essential resource for researchers, professionals, and students alike, providing them with timely reviews, analyses, and perspectives that shape contemporary practice and policy. While lacking open access options, it ensures a critical examination of emerging trends and unique insights that foster informed discussions. With its consistently high impact factor, CURRENT OPINION IN INFECTIOUS DISEASES remains a vital platform for thought leaders and innovators navigating the complexities of infectious disease research.
Current HIV/AIDS Reports
Advancing knowledge in HIV/AIDS research.Current HIV/AIDS Reports, published by Springer, is a distinguished scholarly journal that addresses critical developments in the field of HIV/AIDS research. As a leading publication within the Q1 quartiles for both Infectious Diseases and Virology, it serves as an essential platform for researchers and healthcare providers aiming to advance knowledge and practices related to HIV prevention, treatment, and care. With a commitment to publishing innovative studies, reviews, and clinical guidelines, this journal fosters a comprehensive understanding of the complexities surrounding HIV/AIDS. The journal enjoys a robust reputation, evidenced by its impressive Scopus rankings, including a rank of #69 in Infectious Diseases and #21 in Virology, placing it in the top echelons of its field. With an open-access model, *Current HIV/AIDS Reports* significantly enhances the accessibility of crucial research findings to a global audience, driving progress in HIV/AIDS knowledge and public health.
TROPICAL MEDICINE & INTERNATIONAL HEALTH
Uniting voices in the fight against tropical diseases.Tropical Medicine & International Health is a distinguished journal published by Wiley, dedicated to the exploration and dissemination of cutting-edge research in the fields of infectious diseases, parasitology, and public health. With a robust open-access option, the journal facilitates the widespread sharing of information critical to addressing health issues in tropical and international settings. Since its inception in 1996, it has established a significant presence in the academic community, as indicated by its impressive ranking in various Scopus categories, notably positioned in the Q1 quartile for Parasitology and Q2 for both Infectious Diseases and Public Health, reflecting its high influence within these domains. The journal's commitment to advancing knowledge on health challenges prevalent in tropical environments makes it an invaluable resource for researchers, healthcare professionals, and students alike who are dedicated to improving global health outcomes.
Dermatologica Sinica
Transforming Skin Care with Cutting-edge ResearchDermatologica Sinica, published by Wolters Kluwer Medknow Publications, is an esteemed open-access journal in the field of dermatology that has been disseminating critical research since its inception in 2005. With an E-ISSN of 2223-330X and an ISSN of 1027-8117, this journal presents a platform for researchers, clinicians, and students to share cutting-edge findings and advancements in dermatological science. As of 2023, it proudly ranks in the Q2 category of dermatology journals and holds a notable position at rank #62 out of 142 in the Scopus Medicine - Dermatology category, placing it in the 56th percentile for impact. The journal transitioned to an open-access model in 2016, enhancing accessibility and visibility for groundbreaking studies worldwide. With a commitment to fostering innovation in the dermatological community, Dermatologica Sinica aims to advance the understanding and treatment of skin diseases while encouraging scholarly dialogue among practitioners and researchers across the globe.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV
Bridging Psychological Insights and Socio-Medical StrategiesAIDS CARE - Psychological and Socio-Medical Aspects of AIDS/HIV, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital interdisciplinary platform for researchers, clinicians, and policymakers exploring the complex psychological and socio-medical dimensions of HIV/AIDS. With an ISSN of 0954-0121 and an E-ISSN of 1360-0451, this esteemed journal has been disseminating significant research since 1989 and continues to uphold a commendable reputation in the field, achieving a Q2 ranking in esteemed categories such as Health (Social Science), Public Health, and Social Psychology as per 2023 metrics. Its commitment to enhancing understanding of HIV/AIDS through quantitative and qualitative research makes it essential for stakeholders engaged in health strategies and mental health interventions. While currently not offering open access, the journal provides access to a wealth of authoritative articles that contribute meaningfully to the ongoing discourse surrounding HIV/AIDS and its socio-psychological ramifications. Researchers and students aiming to deepen their knowledge and intervention strategies will find this journal an invaluable resource.
AIDS Research and Therapy
Empowering clinicians with cutting-edge findings.AIDS Research and Therapy is a prestigious peer-reviewed journal dedicated to disseminating cutting-edge research in the fields of AIDS and HIV therapy. Published by BMC, this Open Access journal has been freely available since its inception in 2004, facilitating global access to vital research findings. Based in the United Kingdom, the journal covers a diverse range of topics including molecular medicine, pharmacology, and virology, making it a crucial resource for researchers and clinicians alike. Recognized for its strong impact within the scientific community, it holds a Q2 quartile ranking in multiple categories as of 2023, including Molecular Medicine and Pharmacology. With an aim to enhance understanding and improve clinical outcomes for those affected by HIV/AIDS, AIDS Research and Therapy serves as an essential platform for the exchange of innovative ideas and practices that can inform future therapies and interventions. Researchers, professionals, and students seeking high-quality, peer-reviewed content will find this journal invaluable in advancing their knowledge and efforts in combating the HIV/AIDS epidemic.